The first stem cell-derived GBM organoid was generated from PSCs genetically engineered at different stages of CO formation in order to introduce the driver genetic mutations found in GBM, involving genes such as TP53, EGFR, TERT, PTEN, and CDKN2A/B. Here, CDKN2A is linked to glioblastoma.